Tianda Pharmaceuticals Ltd
HKEX:455
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rossi Residencial SA
BOVESPA:RSID3
|
BR |
Tianda Pharmaceuticals Ltd
Capital Expenditures
Tianda Pharmaceuticals Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tianda Pharmaceuticals Ltd
HKEX:455
|
Capital Expenditures
-HK$42.6m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
Capital Expenditures
-$152.7k
|
CAGR 3-Years
42%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Capital Expenditures
-HK$653.2m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-3%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Capital Expenditures
-¥823.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-3%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Capital Expenditures
-HK$3.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Capital Expenditures
-$24.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-22%
|
|
Tianda Pharmaceuticals Ltd
Glance View
Tianda Pharmaceuticals Ltd. operates as an investment holding company, which engages in the research and development, manufacture and sale of pharmaceutical, biotechnology and healthcare products. The company employs 714 full-time employees The main businesses of the Company include the research and development, production and sales of pharmaceutical, biotechnology and healthcare products. Its products include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. The firm operates businesses in Hong Kong, China and Australia.
See Also
What is Tianda Pharmaceuticals Ltd's Capital Expenditures?
Capital Expenditures
-42.6m
HKD
Based on the financial report for Dec 31, 2025, Tianda Pharmaceuticals Ltd's Capital Expenditures amounts to -42.6m HKD.
What is Tianda Pharmaceuticals Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-20%
Over the last year, the Capital Expenditures growth was 0%. The average annual Capital Expenditures growth rates for Tianda Pharmaceuticals Ltd have been -20% over the past three years .
